12. Share capital (cont’d)
Warrants
7,000,000 warrants set to expire on February 14, 2017 had their term extended until February 14, 2018.
2,685,000 warrants set to expire on March 6, 2017 had their term extended until March 6, 2018.
A summary of the Company’s outstanding warrants as at September 30, 2017 is as follows:
Number of
Warrants
Outstanding
Number of
Warrants
Exercisable
Exercise
Price Expiry Date
10,541,667 10,541,667 $ 0.26 January 7, 2018
7,000,000 7,000,000 $ 0.15 February 14, 2018
2,435,000 2,435,000 $ 0.10 March 6, 2018
22,300,000 23,300,000 $ 0.10 December 13, 2018
42,276,667 42,276,667 $ 0.15
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM